Global Health Equity

As global temperatures continue to rise, so too does the incidence of this mosquito-borne virus. For World Neglected Tropical Disease Day, learn the latest about this growing health threat and how Johnson & Johnson is working to combat it.

For World Neglected Tropical Diseases Day, check out a video highlighting the company’s commitment to caring for children with these common infections across the globe.

As the International AIDS Conference kicks off, learn how a new tool will help give this group greater power to prevent HIV on a monthly basis.

For World Schizophrenia Day, learn about how one inspiring young man with the condition is thriving despite the challenges—and how Johnson & Johnson is helping him and others like him to find new ways to manage their mental illness.

Meet four students dedicated to removing the stigma of mental illness and increasing access to crucial treatments around the world—with the help of the Global Mental Health Scholarship Fund.

A relaunched Johnson & Johnson partnership will help ensure that many young patients get lifesaving access to HIV medicines. Meet a doctor in Kenya who explains why the program is so crucial.

Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who’ve made it their mission to move the world closer to the goal of ending tuberculosis.

It’s one of the world’s deadliest infectious diseases, killing more people each year than HIV/AIDS and malaria combined. We’re taking a look back at the strides the company has made in fighting this preventable illness to help bring us closer to a tuberculosis-free world.

Imagine getting so sick from a preventable disease that you can’t play or attend school—multiple times a year. For World Children’s Day, we’re sharing the story of Sheti and others just like her who now have a chance to take back their childhoods, thanks to a new formulation of a medication to treat intestinal worms.

In response to a new Ebola outbreak in Guinea, Johnson & Johnson is providing up to 200,000 doses of its Ebola vaccine regimen to the country for a World Health Organization supported clinical trial. Learn more about the initiative and other top facts about the vaccine regimen for the deadly virus.